Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Deferoxamine for Diabetic Foot Ulcer Healing
NCT03137966Phase 2Not yet recruiting
- Sponsor
- Karolinska University Hospital
- Start
- Dec 2022
- Primary completion
- Dec 2025
- Modality
- Small Molecules
01
Overview
Phase 2, randomised, double-blind trial of DFO Gel in diabetic foot ulcer (DFU), sponsored by Karolinska University Hospital. Primary endpoint: Wound Healing Rate at 12 weeks. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
DFO Gel
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT03137966.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03137966.